AKT1, AKT2, and AKT3 were reported in very few cases of TC and some AKT1 mutations were reported in ATC and in FTC [44] and in a TC metastasis, suggesting that this mutation can occur late during cancer progression [45]. This evidence concerns the gene AKT1 and cancer.